Treating the problem of white discharge - Traditional vs Innovation.
Phase 2
- Conditions
- Health Condition 1: N898- Other specified noninflammatory disorders of vagina
- Registration Number
- CTRI/2024/03/063470
- Lead Sponsor
- J. S Ayurveda Mahavidyalaya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Married women experiencing leucorrhoea, aged 21-55 years.
2.Willingness to participate and provide informed consent.
3.Patients having any complaint of discharge per vagina, itching sensation at vulva, burning sensation in vagina, pain in vagina, foul smell from vagina, backache and pelvic pain.
Exclusion Criteria
1.Female patients who are pregnant, on breast feeding or post-delivery period.
2.Patients with any reproductive tract malignancy.
3.Patients with other systemic illness.
4.Patients with positive history of venereal diseases.
5.Patients who are using CU-T or chemical method of contraception
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome involves reducing symptoms of leucorrhoea. It is expected that Group A will demonstrate quicker and more efficient results compared to Group B.Timepoint: 14 days
- Secondary Outcome Measures
Name Time Method Improvement in Laboratory investigations - Vaginal Swab, Urine routine and micro and CBC after treatmentTimepoint: 14 days;Improvement in the Quality of life through the measuring scale RAND SF- 36Timepoint: 14 days